Cyclerion Therapeutics Inc (CYCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,232 | 2,872 | 4,588 | 5,696 | 7,571 |
| Receivables | 556 | 44 | N/A | N/A | N/A |
| Other current assets | 16 | 11 | 11 | 10 | 11 |
| TOTAL | $4,225 | $3,548 | $4,715 | $6,014 | $8,024 |
| Non-Current Assets | |||||
| Investments And Advances | 5,350 | 5,350 | 5,350 | 5,350 | 5,350 |
| TOTAL | $5,350 | $5,350 | $5,350 | $5,350 | $5,350 |
| Total Assets | $9,575 | $8,898 | $10,065 | $11,364 | $13,374 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 390 | 304 | 651 | 741 | 1,198 |
| Accrued Expenses | 335 | 396 | 631 | 700 | 888 |
| TOTAL | $725 | $700 | $1,282 | $1,441 | $2,086 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $725 | $700 | $1,282 | $1,441 | $2,086 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,710 | 2,710 | 2,710 | 2,710 | 2,710 |
| Retained earnings | -267,492 | -268,022 | -267,299 | -265,959 | -264,417 |
| Other shareholders' equity | 0 | 0 | 0 | -16 | -12 |
| TOTAL | $8,850 | $8,198 | $8,783 | $9,923 | $11,288 |
| Total Liabilities And Equity | $9,575 | $8,898 | $10,065 | $11,364 | $13,374 |